Gotely may be available in the countries listed below.
Tamsulosin hydrochloride (a derivative of Tamsulosin) is reported as an ingredient of Gotely in the following countries:
International Drug Name Search
Ketotax may be available in the countries listed below.
Ketoprofen is reported as an ingredient of Ketotax in the following countries:
International Drug Name Search
Celascon Vitamin C may be available in the countries listed below.
Ascorbic Acid is reported as an ingredient of Celascon Vitamin C in the following countries:
International Drug Name Search
Pamdosa may be available in the countries listed below.
Pamidronic Acid disodium salt (a derivative of Pamidronic Acid) is reported as an ingredient of Pamdosa in the following countries:
International Drug Name Search
Céfacet may be available in the countries listed below.
Cefalexin is reported as an ingredient of Céfacet in the following countries:
Cefalexin monohydrate (a derivative of Cefalexin) is reported as an ingredient of Céfacet in the following countries:
International Drug Name Search
Enantone L.P. may be available in the countries listed below.
Leuprorelin acetate (a derivative of Leuprorelin) is reported as an ingredient of Enantone L.P. in the following countries:
International Drug Name Search
Fareclox may be available in the countries listed below.
Flucloxacillin sodium salt (a derivative of Flucloxacillin) is reported as an ingredient of Fareclox in the following countries:
International Drug Name Search
Prostavasin may be available in the countries listed below.
Alprostadil alfadex (a derivative of Alprostadil) is reported as an ingredient of Prostavasin in the following countries:
International Drug Name Search
Gentamicina ClNa Baxter may be available in the countries listed below.
Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Gentamicina ClNa Baxter in the following countries:
International Drug Name Search
In the US, Procaine Penicillin (procaine penicillin systemic) is a member of the drug class natural penicillins and is used to treat Anthrax Prophylaxis, Bacterial Infection, Congenital Syphilis, Cutaneous Bacillus anthracis, Diphtheria, Endocarditis, Fusospirochetosis - Trench Mouth, Neurosyphilis, Pneumonia, Rat-bite Fever, Skin Infection, Streptococcal Infection, Syphilis - Early, Syphilis - Latent, Tertiary Syphilis, Tonsillitis/Pharyngitis and Upper Respiratory Tract Infection.
US matches:
Procaine Penicillin (BAN) is also known as Benzylpenicillin (Rec.INN)
International Drug Name Search
Glossary
| BAN | British Approved Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Carvedilolo Winthrop may be available in the countries listed below.
Carvedilol is reported as an ingredient of Carvedilolo Winthrop in the following countries:
International Drug Name Search
Advantix may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Imidacloprid is reported as an ingredient of Advantix in the following countries:
Permethrin is reported as an ingredient of Advantix in the following countries:
International Drug Name Search
Colimycine may be available in the countries listed below.
Colistin is reported as an ingredient of Colimycine in the following countries:
Colistin sulfate (a derivative of Colistin) is reported as an ingredient of Colimycine in the following countries:
Colistin sulphomethate sodium (a derivative of Colistin) is reported as an ingredient of Colimycine in the following countries:
International Drug Name Search
Topiramat Hormosan may be available in the countries listed below.
Topiramate is reported as an ingredient of Topiramat Hormosan in the following countries:
International Drug Name Search
Coszol-D may be available in the countries listed below.
Domperidone is reported as an ingredient of Coszol-D in the following countries:
Omeprazole is reported as an ingredient of Coszol-D in the following countries:
International Drug Name Search
Ketoprofen Vetprom may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Ketoprofen is reported as an ingredient of Ketoprofen Vetprom in the following countries:
International Drug Name Search
Ciprofloxacina Bluepharma may be available in the countries listed below.
Ciprofloxacin is reported as an ingredient of Ciprofloxacina Bluepharma in the following countries:
International Drug Name Search
Mécobalamine may be available in the countries listed below.
Mécobalamine (DCF) is also known as Mecobalamin (Rec.INN)
International Drug Name Search
Glossary
| DCF | Dénomination Commune Française |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
L-Thyroxin Berlin-Chemie may be available in the countries listed below.
Levothyroxine sodium salt (a derivative of Levothyroxine) is reported as an ingredient of L-Thyroxin Berlin-Chemie in the following countries:
International Drug Name Search
Abrolen may be available in the countries listed below.
Ambroxol hydrochloride (a derivative of Ambroxol) is reported as an ingredient of Abrolen in the following countries:
International Drug Name Search
Bexinor may be available in the countries listed below.
Norfloxacin is reported as an ingredient of Bexinor in the following countries:
International Drug Name Search
Inclarin may be available in the countries listed below.
Loratadine is reported as an ingredient of Inclarin in the following countries:
International Drug Name Search
Anapsique may be available in the countries listed below.
Amitriptyline hydrochloride (a derivative of Amitriptyline) is reported as an ingredient of Anapsique in the following countries:
International Drug Name Search
Ranexa 375 mg prolonged-release tablets
Ranexa 500 mg prolonged-release tablets
Ranexa 750 mg prolonged-release tablets
Ranolazine
In addition to this leaflet, you will be given a Patient Alert Card, which contains important safety information that you need to know before you are given Ranexa and during treatment with Ranexa.
1. What Ranexa is and what it is used for
2. Before you take Ranexa
3. How to take Ranexa
4. Possible side effects
5. How to store Ranexa
6. Further information
Ranexa is a medicine used in combination with other medicines to treat angina pectoris, which is a chest pain or discomfort that you feel anywhere along the upper part of your body between your neck and upper abdomen, often brought on by exercise or too much activity.
Speak to your doctor before taking Ranexa:
Your doctor may decide to give you a lower dose or take other precautions if any of these apply to you.
Do not use the following medicines if you take Ranexa:
Tell your doctor or pharmacist before you take Ranexa if you use:
Please tell your doctor or pharmacist if you are using or have recently used any other medicines, including medicines obtained without a prescription.
Ranexa can be taken with or without food. While being treated with Ranexa, you should not drink grapefruit juice.
You should not take Ranexa if you are pregnant unless your doctor has advised you to do so.
You should not take Ranexa if you are breast-feeding. Ask your doctor for advice if you are breast-feeding.
Ask your doctor for advice before using any medicine.
No studies on the effects of Ranexa on the ability to drive and use machines have been performed. Ask your doctor for advice about driving or using machines.
Ranexa may cause side effects such as dizziness (common) and blurred vision (uncommon) that may affect your ability to drive or use machinery. If you experience these symptoms, do not drive or operate machinery until they have resolved completely.
The 750 mg prolonged-release tablets contain the azo colouring agent E102. This colouring agent may cause allergic reactions.
The 750 mg prolonged-release tablets contain lactose monohydrate. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.
Always take Ranexa exactly as your doctor has told you to. You should check with your doctor or pharmacist if you are not sure.
Always swallow the tablets whole with water. Do not crush, suck, or chew the tablets or break them in half, as this might affect the way the medicine is released from the tablets into your body.
The starting dose for adults is one 375 mg tablet twice a day. After 2-4 weeks, your doctor may increase the dose to get the right effect. The maximum dose of Ranexa is 750 mg twice a day.
It is important that you tell your doctor if you get side effects such as dizziness or feeling or being sick. Your doctor may lower your dose or, if this is not sufficient, stop treatment with Ranexa.
Children and adolescents under 18 years old should not take Ranexa.
If you accidentally take too many Ranexa tablets or take a higher dose than recommended by your doctor, it is important that you tell your doctor at once. If you cannot contact your doctor, go to the nearest accident and emergency department. Take along any tablets that are left, including the container and the carton, so that the hospital staff can easily tell what you have taken.
If you forget to take a dose, take it as soon as you remember unless it is nearly time to take your next dose. Do not take a double dose to make up for a forgotten dose.
Like all medicines, Ranexa can cause side effects, although not everybody gets them. These are usually mild or moderate.
You should stop taking Ranexa and see your doctor immediately if you experience the following symptoms of angioedema, which is a rare condition but can be severe:
Tell your doctor if you experience common side effects such as dizziness or feeling sick or vomiting. Your doctor may lower your dose or stop treatment with Ranexa.
Other side effects you may experience include the following:
Common side effects (occur in 1 to 10 users in 100) are:
Constipation
Dizziness
Headache
Feeling sick, vomiting
Feeling weak
Uncommon side effects (occur in 1 to 10 users in 1,000) are:
Anxiety, difficulty sleeping
Blurred vision, visual disturbance
Changes in sensation (touch or taste), tremor, feeling tired or sluggish, sleepiness or drowsiness, faint or fainting, dizziness upon standing
Dark urine, blood in urine, difficulty urinating
Dehydration
Difficulty breathing, cough, nose bleed
Excessive sweating, itching
Feeling swollen or bloated
Hot flushes, low blood pressure
Increases in a substance called creatinine or increases in urea in your blood, increase in blood platelets or white blood cells, changes in ECG heart tracing
Joint swelling, pain in extremity
Loss of appetite and/or weight loss
Muscle cramp
Ringing in the ears and/or feeling a spinning sensation
Stomach pain or discomfort, indigestion, dry mouth, or wind
Rare side effects (occur in 1 to 10 users in 10,000) are:
Abnormal laboratory values for liver
Change in sense of smell, numbness in mouth or lips, impaired hearing
Cold sweat, rash
Decrease in blood pressure upon standing
Decreased or loss of consciousness
Disorientation
Feeling of coldness in hands and legs
Hives, allergic skin reaction
Impotence
Inflammation of pancreas or intestine
Loss of memory
Throat tightness
In some isolated cases, acute kidney failure has been reported with the use of Ranexa.
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
Keep out of the reach and sight of children.
Do not use Ranexa after the expiry date which is stated on each blister strip of tablets and on the outside of the carton and bottle.
This medicinal product does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
The active substance in Ranexa is ranolazine. Each tablet contains 375 mg, 500 mg, or 750 mg ranolazine.
The other ingredients are: hypromellose, magnesium stearate, methacrylic acid-ethyl acrylate copolymer, microcrystalline cellulose, sodium hydroxide, titanium dioxide and carnauba wax.
Depending on the tablet strength, the tablet coatings also contain:
375 mg tablet: macrogol, polysorbate 80, Blue #2/Indigo Carmine Aluminium Lake (E132)
500 mg tablet: macrogol, talc, polyvinyl alcohol-part hydrolyzed, iron oxide yellow (E172), iron oxide red (E172)
750 mg tablet: glycerol triacetate, lactose monohydrate, Blue #1/Brilliant Blue FCF Aluminium Lake (E133) and Yellow #5/Tartrazine Aluminium Lake (E102)
Ranexa prolonged-release tablets are oval shaped tablets.
The 375 mg tablets are pale blue and are engraved with CVT375 or 375 on one side.
The 500 mg tablets are light orange and are engraved with CVT500 or 500 on one side.
The 750 mg tablets are pale green and are engraved with CVT750 or 750 on one side.
Ranexa is supplied in cartons containing 30, 60, or 100 tablets in blister strips or 60 tablets in plastic bottles. Not all pack-sizes may be marketed.
or
or
or
For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder.
This leaflet was last approved in 07/2010.
Detailed information on this medicine is available on the website of the European Medicines Agency (EMEA) http://www.emea.europa.eu/.
Ranexa Patient Alert Card
(Carry this card with you at all times)
This card contains important safety information you should know before you are given Ranexa and during treatment with Ranexa.
Before taking Ranexa speak to your doctor if you:
Dates of Ranexa treatment:
Start………………………
Patient’s name…………………………..
Doctor’s name…………………………..
Doctor’s phone………………………….
Tomit may be available in the countries listed below.
Metoclopramide hydrochloride (a derivative of Metoclopramide) is reported as an ingredient of Tomit in the following countries:
International Drug Name Search
Millibar may be available in the countries listed below.
Indapamide is reported as an ingredient of Millibar in the following countries:
Indapamide hemihydrate (a derivative of Indapamide) is reported as an ingredient of Millibar in the following countries:
International Drug Name Search
Cyprotérone/Ethinylestradiol Zydus may be available in the countries listed below.
Cyproterone 17α-acetate (a derivative of Cyproterone) is reported as an ingredient of Cyprotérone/Ethinylestradiol Zydus in the following countries:
Ethinylestradiol is reported as an ingredient of Cyprotérone/Ethinylestradiol Zydus in the following countries:
International Drug Name Search
Ramed may be available in the countries listed below.
Ramipril is reported as an ingredient of Ramed in the following countries:
International Drug Name Search
Masletine may be available in the countries listed below.
Clemastine fumarate (a derivative of Clemastine) is reported as an ingredient of Masletine in the following countries:
International Drug Name Search
Triamcinolone esacetonide may be available in the countries listed below.
Triamcinolone esacetonide (DCIT) is known as Triamcinolone in the US.
International Drug Name Search
Glossary
| DCIT | Denominazione Comune Italiana |
PMS-Calcium may be available in the countries listed below.
Calcium Carbonate is reported as an ingredient of PMS-Calcium in the following countries:
International Drug Name Search
Metazole may be available in the countries listed below.
Metronidazole benzoate (a derivative of Metronidazole) is reported as an ingredient of Metazole in the following countries:
International Drug Name Search
Kwell may be available in the countries listed below.
Permethrin is reported as an ingredient of Kwell in the following countries:
International Drug Name Search
Pondperdone may be available in the countries listed below.
Domperidone is reported as an ingredient of Pondperdone in the following countries:
International Drug Name Search
Anoxen may be available in the countries listed below.
Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Anoxen in the following countries:
International Drug Name Search
Uniphyllin
Continus
200 mg, 300 mg and 400 mg prolonged-release tablets
Theophylline
This medicine is available without prescription. However you still need to take Uniphyllin Continus tablets carefully to get the best results from them.
These tablets are used to treat asthma, long-term breathing difficulties such as chronic obstructive pulmonary disease and chronic bronchitis, and are sometimes used to treat heart failure.
They contain the active ingredient theophylline which belongs to a group of medicines called bronchodilators. Bronchodilators help stop you wheezing and being breathless. Theophylline also reduces swelling in the lungs of asthma patients and relieves the feeling of ‘tightness’ in their chest.
Before treatment with these tablets tell your doctor or pharmacist if you:
Children under seven years of age should not take these tablets.
Tell your doctor or pharmacist if you are taking:
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. If you take these tablets with some other medicines, the effect of these tablets or the other medicine may be changed.
Alcohol can alter the way these tablets work. Please consult your doctor if you intend to drink alcohol whilst taking these tablets.
If you are pregnant or breastfeeding do not take these tablets until you have talked to your doctor or pharmacist.
Ask your doctor or pharmacist for advice before taking any medicine.
Always take these tablets exactly as your doctor or pharmacist has told you.
Swallow your tablets whole with a glass of water. Do not crush or chew them.
Uniphyllin Continus tablets are designed to work properly over 12 hours. If a tablet is crushed or chewed the entire 12-hour dose may be absorbed rapidly into your body. This can be dangerous, causing serious problems such as an overdose.
You should take your tablets every 12 hours. For instance, if you take a tablet at 8 o’clock in the morning, you should take your next tablet at 8 o’clock in the evening.
The usual starting dose for adults is one 200 mg tablet every 12 hours. Your doctor may increase your dose to one 300 mg or 400 mg tablet every 12 hours, depending upon how you respond to treatment. If you are elderly your doctor may suggest a lower dose.
Children over seven years of age can take these tablets. The required dose will depend on their weight and the severity of their breathing problems. This should be discussed with your doctor or pharmacist.
Do not exceed the dose recommended by your doctor. You should check with your doctor or pharmacist if you are not sure.
Call your doctor or hospital straight away. People who have taken an overdose may have stomach pains and feel or be sick. They may also have a fast or irregular heartbeat, feel very restless or have a fit. These symptoms may appear up to 12 hours after the overdose. When seeking medical attention make sure that you take this leaflet and any remaining tablets with you to show the doctor.
If you remember within 4 hours of the time your tablet was due, take your tablet straight away. Take your next tablet at your normal time. If you are more than 4 hours late, please call your doctor or pharmacist for advice. Do not take a double dose to make up for a forgotten tablet.
You will probably take these tablets for a long time. Do not stop taking them unless your doctor tells you to, even if you feel better.
If you have any further questions on the use of these tablets, ask your doctor or pharmacist.
Like all medicines, these tablets can cause side effects, although not everybody gets them.
All medicines can cause allergic reactions, although serious allergic reactions are rare. Tell your doctor immediately if you get any sudden wheeziness, difficulties in breathing, swelling of the eyelids, face or lips, rash or itching especially those covering your whole body.
The following side effects have been reported in patients treated with these tablets:
If any of the side effects become serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
Keep out of the reach and sight of children.
Do not use any tablets after the expiry date stated on the outer carton and blister pack. EXP 08 2010 means that you should not take the tablets after the last day of that month i.e. August 2010.
Do not store your tablets above 25ºC.
Do not take your tablets if they are broken or crushed as this can be dangerous and can lead to serious problems such as overdose.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
The active ingredient is theophylline. Each tablet contains 200 mg, 300 mg or 400 mg of theophylline.
The other ingredients are:
The tablets are white and capsule shaped. The 200 mg and 300 mg tablets are marked with a scoreline on one side and the strength (e.g. U200, U300 etc.) on the other. The 400 mg tablets are marked Uniphyllin on one side and with NAPP and the strength on either side of the scoreline on the reverse.
In each box there are 56 tablets.
The tablets are made by Bard Pharmaceuticals Limited for the marketing authorisation holder
This leaflet is also available in large print, Braille or as an audio CD. To request a copy, please call the RNIB Medicine Information line (free of charge) on:
0800 198 5000
You will need to give details of the product name and reference number.
These are as follows:
Product name: Uniphyllin Continus tablets
Reference number: 16950/0066
This leaflet was last revised in February 2010.
Uniphyllin, Continus,
NAPP and the NAPP device (logo) are Registered Trade Marks.
© 2008 - 2010 Napp Pharmaceuticals Limited
6152-11
Fluvet may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Cromoglicic Acid disodium salt (a derivative of Cromoglicic Acid) is reported as an ingredient of Fluvet in the following countries:
Flumetasone is reported as an ingredient of Fluvet in the following countries:
International Drug Name Search
Isoket Retard may be available in the countries listed below.
Isosorbide Dinitrate is reported as an ingredient of Isoket Retard in the following countries:
International Drug Name Search
Amoxicillina ABC may be available in the countries listed below.
Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoxicillina ABC in the following countries:
International Drug Name Search
Litheum may be available in the countries listed below.
Lithium carbonate (a derivative of Lithium) is reported as an ingredient of Litheum in the following countries:
International Drug Name Search
Amavita Acetylcystein may be available in the countries listed below.
Acetylcysteine is reported as an ingredient of Amavita Acetylcystein in the following countries:
International Drug Name Search
Calciumchlorid Baxter may be available in the countries listed below.
Calcium Chloride dihydrate (a derivative of Calcium Chloride) is reported as an ingredient of Calciumchlorid Baxter in the following countries:
International Drug Name Search
Relifen may be available in the countries listed below.
Nabumetone is reported as an ingredient of Relifen in the following countries:
International Drug Name Search
Evsten may be available in the countries listed below.
Nicorandil is reported as an ingredient of Evsten in the following countries:
International Drug Name Search
Carbolit may be available in the countries listed below.
Lithium carbonate (a derivative of Lithium) is reported as an ingredient of Carbolit in the following countries:
International Drug Name Search
Erizole may be available in the countries listed below.
Mebendazole is reported as an ingredient of Erizole in the following countries:
International Drug Name Search
Ranitidin may be available in the countries listed below.
Ranitidine is reported as an ingredient of Ranitidin in the following countries:
Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Ranitidin in the following countries:
International Drug Name Search
Ampicilina MF may be available in the countries listed below.
Ampicillin is reported as an ingredient of Ampicilina MF in the following countries:
International Drug Name Search
Monasosal may be available in the countries listed below.
Pemirolast potassium salt (a derivative of Pemirolast) is reported as an ingredient of Monasosal in the following countries:
International Drug Name Search
Labetalol HCl Katwijk may be available in the countries listed below.
Labetalol hydrochloride (a derivative of Labetalol) is reported as an ingredient of Labetalol HCl Katwijk in the following countries:
International Drug Name Search
UK matches:
Sodium Phosphate Dibasic (a derivative of Sodium Phosphate) is reported as an ingredient of Fleet Phospho-Soda in the following countries:
Sodium Phosphate Dibasic dodecahydrate (a derivative of Sodium Phosphate) is reported as an ingredient of Fleet Phospho-Soda in the following countries:
Sodium Phosphate Monobasic (a derivative of Sodium Phosphate) is reported as an ingredient of Fleet Phospho-Soda in the following countries:
Sodium Phosphate Monobasic dihydrate (a derivative of Sodium Phosphate) is reported as an ingredient of Fleet Phospho-Soda in the following countries:
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
Amoxyclav may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoxyclav in the following countries:
Clavulanic Acid potassium (a derivative of Clavulanic Acid) is reported as an ingredient of Amoxyclav in the following countries:
International Drug Name Search
Minisec may be available in the countries listed below.
Omeprazole is reported as an ingredient of Minisec in the following countries:
International Drug Name Search
Atropine Sulfate Mylan may be available in the countries listed below.
Atropine sulfate (a derivative of Atropine) is reported as an ingredient of Atropine Sulfate Mylan in the following countries:
International Drug Name Search
Armaseft may be available in the countries listed below.
Ceftriaxone disodium salt (a derivative of Ceftriaxone) is reported as an ingredient of Armaseft in the following countries:
International Drug Name Search
Hexplider-C may be available in the countries listed below.
Paracetamol is reported as an ingredient of Hexplider-C in the following countries:
Scopolamine is reported as an ingredient of Hexplider-C in the following countries:
International Drug Name Search
Metformin Beacons may be available in the countries listed below.
Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Metformin Beacons in the following countries:
International Drug Name Search
Monosor may be available in the countries listed below.
Isosorbide Mononitrate is reported as an ingredient of Monosor in the following countries:
International Drug Name Search
Clotrimazol MK may be available in the countries listed below.
Clotrimazole is reported as an ingredient of Clotrimazol MK in the following countries:
International Drug Name Search
Meto-Succinat HCT Sandoz may be available in the countries listed below.
Hydrochlorothiazide is reported as an ingredient of Meto-Succinat HCT Sandoz in the following countries:
Metoprolol succinate (a derivative of Metoprolol) is reported as an ingredient of Meto-Succinat HCT Sandoz in the following countries:
International Drug Name Search
Avertin may be available in the countries listed below.
Betahistine dihydrochloride (a derivative of Betahistine) is reported as an ingredient of Avertin in the following countries:
International Drug Name Search
Fidagenbeta may be available in the countries listed below.
Betamethasone 17α-valerate (a derivative of Betamethasone) is reported as an ingredient of Fidagenbeta in the following countries:
Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Fidagenbeta in the following countries:
International Drug Name Search
Itracol may be available in the countries listed below.
Itraconazole is reported as an ingredient of Itracol in the following countries:
International Drug Name Search
Bisoprolol Labiana may be available in the countries listed below.
Bisoprolol fumarate (a derivative of Bisoprolol) is reported as an ingredient of Bisoprolol Labiana in the following countries:
International Drug Name Search
Pyretinol may be available in the countries listed below.
Paracetamol is reported as an ingredient of Pyretinol in the following countries:
International Drug Name Search
Azaphen may be available in the countries listed below.
Pipofezine hydrochloride (a derivative of Pipofezine) is reported as an ingredient of Azaphen in the following countries:
International Drug Name Search
Carboplatino Ferrer Farma may be available in the countries listed below.
Carboplatin is reported as an ingredient of Carboplatino Ferrer Farma in the following countries:
International Drug Name Search
Astomari may be available in the countries listed below.
Dextromethorphan hydrobromide (a derivative of Dextromethorphan) is reported as an ingredient of Astomari in the following countries:
International Drug Name Search
Paracetamol Fortbenton may be available in the countries listed below.
Paracetamol is reported as an ingredient of Paracetamol Fortbenton in the following countries:
International Drug Name Search
Bicrolid may be available in the countries listed below.
Clarithromycin is reported as an ingredient of Bicrolid in the following countries:
International Drug Name Search
Camnovate may be available in the countries listed below.
Betamethasone 17α-valerate (a derivative of Betamethasone) is reported as an ingredient of Camnovate in the following countries:
International Drug Name Search
Fludarabine Actavis may be available in the countries listed below.
Fludarabine phosphate (a derivative of Fludarabine) is reported as an ingredient of Fludarabine Actavis in the following countries:
International Drug Name Search
Irapen may be available in the countries listed below.
Ampicillin is reported as an ingredient of Irapen in the following countries:
International Drug Name Search
Intestifalk may be available in the countries listed below.
Budesonide is reported as an ingredient of Intestifalk in the following countries:
International Drug Name Search
Ciclofosfamida Microsules may be available in the countries listed below.
Cyclophosphamide is reported as an ingredient of Ciclofosfamida Microsules in the following countries:
International Drug Name Search
Rhinoside may be available in the countries listed below.
Budesonide is reported as an ingredient of Rhinoside in the following countries:
International Drug Name Search
Praxavet Pen may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Benzylpenicillin procaine (a derivative of Benzylpenicillin) is reported as an ingredient of Praxavet Pen in the following countries:
International Drug Name Search
Lorazepam Vannier may be available in the countries listed below.
Lorazepam is reported as an ingredient of Lorazepam Vannier in the following countries:
International Drug Name Search
Karvol Decongestant Drops
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Inhalation vapour, liquid
For the symptomatic relief of nasal congestion and colds in the head.
For older children and adults:
For relief throughout the night: sprinkle 6 drops onto bedding or handkerchief nearby but avoiding direct skin contact.
Daytime: sprinkle 6 drops onto a tissue or into a pint of hot water and inhale the vapours freely.
For young children:
For daytime use and relief throughout the night: sprinkle 6 drops onto a handkerchief tied down securely in the vicinity but out of reach of the child..
Elderly: There is no need to modify the administration of this preparation for use by the elderly.
Children under 3 months: Not recommended for children under 3 months.
Children under 3 months of age
Avoid contact with the eyes and prolonged contact with the skin.
If symptoms persist consult your doctor.
Keep all medicines out of the reach of children.
For inhalation only.
Do not put drops directly in mouth or nose.
No clinically significant interactions known.
The safety in pregnancy and lactation has not been established but it is not expected to constitute a hazard.
No adverse effects known.
None known.
Symptoms of massive overdose by ingestion include nausea, vomiting, colic, headache, dizziness, a feeling of warmth, delirium, muscle twitching, epileptiform convulsions, depressed respiration, CNS depression and coma. Initial treatment consists of emptying the stomach by lavage and aspiration. Administer a saline laxative such as sodium sulphate and activated charcoal by mouth. Convulsions may be controlled with diazepam or thiopental sodium.
Chlorobutanol, levomenthol, pine oil, terpineol and thymol are volatile substances and are thought to produce an irritant effect on the respiratory tract, possibly via a nasal/pulmonary arc.
Not applicable.
There are no preclinical safety data of relevance to the consumer.
Macrogol Stearate,
Cinnamon Oil,
Polysorbate 80,
Polyethylene Glycol 400,
Triacetin.
Not applicable.
24 months.
Do not store above 25°C.
The liquid is contained in an amber glass bottle fitted with a combined all in one polyethylene/polypropylene dropper and a tamper evident child resistant polypropylene cap, or a non child resistant polypropylene cap. The bottle is presented in a cardboard carton.
Whilst applying drops ensure that the dropper bottle is held vertically.
Reckitt Benckiser Healthcare (UK) Limited
Dansom Lane
Hull
HU8 7DS
United Kingdom
PL 00063/0406
08 May 1997
25 January 2008
Bupisolver may be available in the countries listed below.
Bupivacaine hydrochloride (a derivative of Bupivacaine) is reported as an ingredient of Bupisolver in the following countries:
International Drug Name Search
Coldrex Broncho may be available in the countries listed below.
Guaifenesin is reported as an ingredient of Coldrex Broncho in the following countries:
International Drug Name Search
In the US, Propafenone (propafenone systemic) is a member of the drug class group I antiarrhythmics and is used to treat Atrial Fibrillation, Atrial Flutter, Ventricular Tachycardia and Wolff-Parkinson-White Syndrome.
US matches:
Rec.INN
C01BC03
0054063-53-5
C21-H27-N-O3
341
Antiarrhythmic agent
1-Propanone, 1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenyl-
International Drug Name Search
Glossary
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
